Management of Mild Asthma Exacerbations

Immediate Relief Therapy

The American Academy of Family Physicians recommends using an inhaled short-acting beta-agonist (SABA) such as albuterol 2-4 puffs every 4 hours as needed for symptom relief, and if the patient is not already on controller therapy, initiate or intensify inhaled corticosteroid therapy immediately 1, 2
Inhaled short-acting beta-agonists are the most effective therapy for rapid reversal of airflow obstruction and prompt relief of asthmatic symptoms, according to the American Family Physician 1
Administer albuterol 2-4 puffs via metered-dose inhaler (MDI) with spacer every 4 hours as needed for symptoms, as recommended by the Journal of Allergy and Clinical Immunology 3, 2
If using an MDI, administer through a valved holding chamber (spacer) to optimize drug delivery, as suggested by the Journal of Allergy and Clinical Immunology 2

Increasing use of short-acting beta-agonists or using them more than two days per week generally indicates inadequate control of asthma and the need to initiate or intensify anti-inflammatory therapy, according to the American Family Physician 1
If the patient requires SABA more than 2 days per week for symptom relief, this signals inadequate asthma control, as stated by the American Family Physician and Praxis Medical Insights 1, 4
If symptoms occur more than 2 nights per month, controller therapy must be initiated or stepped up, as recommended by the American Family Physician 1

For patients aged 12 years and older with mild persistent asthma experiencing a flare-up, either initiate daily low-dose inhaled corticosteroids with as-needed SABA, or use as-needed ICS and SABA concomitantly, as suggested by the Journal of Allergy and Clinical Immunology 3
Start low-dose inhaled corticosteroid (fluticasone 100-250 mcg/day or equivalent) twice daily, and continue as-needed SABA for breakthrough symptoms, as recommended by Praxis Medical Insights and the American Family Physician 5, 1
Administer 2-4 puffs of albuterol followed by 80-250 μg of beclomethasone equivalent every 4 hours as needed for symptoms, as suggested by the Journal of Allergy and Clinical Immunology 3

Oral systemic corticosteroids should be used to treat moderate to severe asthma exacerbations, according to the American Family Physician 1
If the patient has poor response to initial SABA treatment (3 doses over 60-90 minutes), consider oral corticosteroids, as recommended by the Journal of Allergy and Clinical Immunology 2
If FEV1 or peak flow remains <40% of predicted after initial bronchodilator therapy, systemic steroids are indicated, as suggested by the Journal of Allergy and Clinical Immunology 2

Never use SABA as monotherapy for ongoing management without addressing underlying inflammation, as stated by the American Family Physician and Praxis Medical Insights 1, 5
Never use long-acting beta-agonists as monotherapy without inhaled corticosteroids, as this increases risk of exacerbations, according to the American Family Physician and Praxis Medical Insights 1, 5
Do not withhold inhaled corticosteroids based on absence of wheeze—asthma can present without audible wheeze, and ICS remain first-line treatment regardless of physical examination findings, as recommended by Praxis Medical Insights 5

Reassess asthma control every 2-6 weeks initially after starting or intensifying treatment, as suggested by Praxis Medical Insights 5
If no clear benefit within 4-6 weeks, reconsider alternative diagnoses or step up therapy, as recommended by Praxis Medical Insights 5
Monitor for adequate symptom control: daytime symptoms ≤2 days/week, nighttime awakenings ≤2 nights/month, SABA use ≤2 days/week, as stated by Praxis Medical Insights 4
Measure peak expiratory flow to objectively assess treatment response, as recommended by Praxis Medical Insights 4